NCT04406662 Routine Evaluation of People Living With Cancer
| NCT ID | NCT04406662 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Edinburgh |
| Condition | Cachexia; Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 600 participants |
| Start Date | 2020-07-15 |
| Primary Completion | 2029-08-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 600 participants in total. It began in 2020-07-15 with a primary completion date of 2029-08-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
People with incurable cancer often have complex individual needs, however there are several common themes encountered when considering this group. As cancer progresses there are series of interactions between the tumour and the patient, producing both local and systemic effects. This altered state of illness can have multiple ill effects including weight loss, fatigue, increased symptom burden and reduction in physical function which all contribute to a reduced quality of life. These areas are often studied in isolation, giving an incomplete picture. A detailed, holistic characterisation of this group of people does not exist. A robust characterisation of people with incurable cancer will allow identification and prioritisation of future research and has the potential to inform new therapeutics and provide justification for treatments. This study aims to collect information about symptoms and quality of life, weight loss and body composition, physical activity and the body's immune response to cancer. Participants with incurable cancer will be recruited to the study from oncology and palliative medicine services in the UK. Participants will answer questionnaires about quality of life and symptoms, have bloods taken for inflammatory marker and cytokine analysis and have their body composition measured by a variety of methods.
Eligibility Criteria
Inclusion Criteria: * Patients with incurable cancer (metastatic cancer (Clinical, histological, cytological or radiological evidence) or receiving anti-cancer therapy with palliative intent). * Aged 18-years and over * Written informed consent Exclusion Criteria: * Any concomitant medical or psychiatric problems which, in the opinion of the investigator, would increase the risk of complication for the participant and/or investigator. * Participants will not be able to take part in bio-impedance analysis if they have a pacemaker or implantable cardiac defibrillator.
Contact & Investigator
Barry JA Laird, MBCHB MD
PRINCIPAL INVESTIGATOR
St Columba's Hospice/ University of Edinburgh
Frequently Asked Questions
Who can join the NCT04406662 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cachexia; Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04406662 currently recruiting?
Yes, NCT04406662 is actively recruiting participants. Contact the research team at barry.laird@ed.ac.uk for enrollment information.
Where is the NCT04406662 trial being conducted?
This trial is being conducted at Edinburgh, United Kingdom.
Who is sponsoring the NCT04406662 clinical trial?
NCT04406662 is sponsored by University of Edinburgh. The principal investigator is Barry JA Laird, MBCHB MD at St Columba's Hospice/ University of Edinburgh. The trial plans to enroll 600 participants.
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.